Bausch + Lomb is an eye-health company that makes contact lenses, lens-care products, ophthalmic pharmaceuticals, and surgical devices for vision care.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Steve Cohen / Point72 | 75 | Added +49% | 261,436 | $4,444,402 | 0.0% |
| Daniel Loeb / Third Point | 39 | Holds (flat) | 85,000 | $1,445,000 | 0.0% |
| Larry Robbins / Glenview | 61 | Trimmed -2% | 1,880,411 | $31,966,987 | 0.5% |
| Carl Icahn | 5 | Trimmed -32% | 2,378,100 | $40,427,700 | 0.4% |
| Paul Tudor Jones / Tudor | 61 | Trimmed -36% | 341,679 | $5,808,543 | 0.0% |
| Filed | Insider | Role | Shares | Value | |
|---|---|---|---|---|---|
| 2026-03-10 | SAUNDERS BRENT L (cluster of 3) | director+officer | 14,700 | $251,958 | Form 4 |
| 2026-03-10 | Bailey A Robert D (cluster of 3) | officer | 14,600 | $250,390 | Form 4 |
| 2026-02-24 | COLLIS STEVEN H (cluster of 3) | director | 15,000 | $267,150 | Form 4 |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.